Intraoperative Imaging Device Articles & Analysis
4 news found
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach with the aim to improve cancer surgery and clinical outcomes for patients, today announces that the first US patient has been recruited into its on-going pivotal Phase 3 clinical trial evaluating its investigational imaging agent SGM-101 in patients undergoing colorectal cancer (CRC) surgery. ...
BySurgiMab
SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach designed to improve cancer surgery and clinical outcomes for patients, today announces that the first surgical procedure was carried out in a pivotal Phase 3 clinical trial of the Company's lead product, SGM-101, in a patient with colorectal cancer (CRC). SGM-101 is a tumor-specific antibody ...
BySurgiMab
nView medical CEO, Cristian Atria, was recently in Singapore attending a Utah trade mission led by Utah Governor Gary R. Herbert. The Utah mission focused in building relationships between Utah and Singapore, including building business partnerships, investments, sharing best practices and of course spurring import/export & trade. The delegation was composed of key business people, ...